Search

Press release

SPHINGONY has been recognized as one of the innovative products in the category naturals/actives at in-cosmetics 2014

Essen, April 9, 2014
  • Skin identical molecule rebalancing the life cycle of the hair

  • Healthy scalp, reduced hair loss

Evonik’s latest Hair & Scalp Care active ingredient SPHINGONY, has won a BSB Innovation Award 2014.

Having healthy hair embedded in a healthy scalp is essential to prevent hair loss. SPHINGONY is a naturally occurring, skin-identical sphingolipid which prevents hair loss by addressing scalp health and rebalancing the life cycle of the hair. SPHINGONY is COSMOS certified and approved by Ecocert Greenlife according to the Ecocert Standard for Natural and Organic Cosmetics, available at http://cosmetics.ecocert.com.

The BSB Innovation Award highlights the best finished goods and ingredients in four different categories. Each prize winner is selected by an international and independent jury that consists of industry professionals from leading players.

Winners were announced at the award ceremony at in-cosmetics 2014 in Hamburg.

Please find appropriate further information on SPHINGONY on our Personal Care website: www.evonik.com/personal-care

Downloads

Linked Files

BSB
Award_Big
Contact

Janna Hullmann

Vice President Communications Consumer Specialties

Lisa Dierks

Global Marketing Communication Manager / Personal Care Consumer Specialties

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders
    in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.